Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma
Kei Yamane·Etsuro Hatano·Takayuki Anazawa·A. Sato·Yu Hidaka·Takafumi Machimoto·Rei Toda·Yosuke Kasai·Kenya Yamanaka·Kentaro Yasuchika·Kazuhiko Kitaguchi·Toshiyuki Hata·Koji Doi·Yumiko Ibi·Akira Mori·Shintaro Yagi·Kohta Iguchi·Yuichiro Uchida·Toshihiko Masui·Naoya Sasaki·Yusuke Okamura·Koji Kitamura·Masato Narita·Takashi Komatsubara·Kunihiko Tsuboi·Kazuyuki Nagai·Yukihiro Okuda·Yusuke Uemoto
MPR was independently associated with favorable survival in PDAC. The prognostic impact of adjuvant chemotherapy was not observed among patients who achieved MPR, suggesting that MPR may inform individualized postoperative management and warrants prospective validation.